Publication Name	World Journal of Dermatology
Manuscript ID	4577
Country	Japan

Received	2013-07-08 09:53
Peer-Review Started	2013-07-08 14:17
First Decision by Editorial Office Director
Return for Revision	2013-08-01 11:14
Revised	2013-08-14 10:23
Publication Fee Transferred
Second Decision by Editor	2013-09-03 14:29
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2013-09-04 07:37
Articles in Press
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-09-29 14:12
Publish the Manuscript Online	2013-10-31 15:06

ISSN	2218-6190 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Dermatology
Manuscript Type	Minireviews
Article Title	Potential biomarkers for malignant melanoma
Manuscript Source	Invited Manuscript
All Author List	Ye-Nan Wang, Yuki Yamamoto and Fukumi Furukawa
Funding Agency and Grant Number
Corresponding Author	Ye-Nan Wang, MD, Department of Dermatology, Wakayama Medical University, 811-1, Kimiidera, Wakayama City, Wakayama 641-0012, Japan. wangyenan1112@live.cn
Key Words	Melanoma; Prognosis; Survival; Biological marker; Immunohistochemistry
Core Tip	Melanoma is one of the most common cancers and its high metastatic potential has a large impact on the number of melanoma deaths. Emerging molecular knowledge may lead to further identification of clinically relevant biomarkers, such as S100B, MIA, TA-90IC, 5-S-CD, SPARC, CSPG4, HSP105, IMP3, KIF2A, miR-221, YKL-40, some cancer stem cells (CD133, Nestin, CD166, CD20, CD271) and some monoclonal antibodies (KBA62, PNL2), for malignant melanoma detection, risk stratification and prediction/prognosis. However, all current markers have some shortcomings and thus we expect there will be more novel melanoma biomarkers discovered as supplementary diagnostic criteria in the near future.
Publish Date	2013-10-31 15:06
Citation	Wang YN, Yamamoto Y, Furukawa F. Potential biomarkers for malignant melanoma. World J Dermatol 2013; 2(4): 44-50
URL	http://www.wjgnet.com/2218-6190/full/v2/i4/44.htm
DOI	http://dx.doi.org/10.5314/wjd.v2.i4.44

Full Article (PDF)	WJD-2-44.pdf
Manuscript File	4577-Review.docx
Answering Reviewers	4577-Answering reviewers.pdf
Copyright License Agreement	4577-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	4577-Language certificate.pdf
Peer-review Report	4577-Peer review(s).pdf
Scientific Editor Work List	4577-Scientific editor work list.doc